Nobel Prize Recognizes AI-driven Drug Development

The Royal Swedish Academy of Sciences recently made a release regarding the 2024 Nobel Prize in Chemistry to three individuals for...

First circRNA Therapy Enters Clinical Trials

Head and neck tumors are the sixth most common malignant tumor worldwide, with a gradually increasing incidence, and may develop...

FDA Establishes AI Council to Improve Regulatory System

As artificial intelligence (AI) has become a big driver of healthcare and biomedicine, regulators have new concerns. There has been...

AI Model TxGNN Repositions Drugs for Rare Diseases

Of the more than 7,000 rare diseases worldwide, only about 5-7% have corresponding FDA-approved drug treatments...

GenAI in the Pharmaceutical Industry

Generative AI (GenAI), a critical branch of AI, focuses more on generation and creation than traditional AI...